J.W. Cole Advisors Inc. Reduces Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

J.W. Cole Advisors Inc. lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 47.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,243 shares of the financial services provider’s stock after selling 2,902 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $445,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of IBB. Future Financial Wealth Managment LLC bought a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $27,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF in the second quarter valued at about $31,000. Pacifica Partners Inc. grew its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares in the last quarter. Crewe Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 42.9% during the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new position in iShares Biotechnology ETF during the first quarter worth $37,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.2 %

NASDAQ IBB opened at $147.83 on Wednesday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.17. The company has a fifty day simple moving average of $145.31 and a 200 day simple moving average of $138.35.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.